Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study (Q31834528)

4 July 2017

title

Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study (English)

1 reference

4 July 2017

1 reference

coronary artery disease

1 reference

Feldman HA

1

1 reference

4 July 2017

Johannes CB

2

1 reference

4 July 2017

Araujo AB

3

1 reference

4 July 2017

Mohr BA

4

1 reference

4 July 2017

Longcope C

5

1 reference

4 July 2017

McKinlay JB

6

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Epidemiology

4 July 2017

published in

1 reference

4 July 2017

volume

153

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

79-89

1 reference

Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate: Their Relation to Cardiovascular Disease

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

The relationship of natural androgens to coronary heart disease in males: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Longitudinal changes in dehydroepiandrosterone concentrations in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Dehydroepiandrosterone and diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

DHEA and DHEA-S: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

DHEA: a biologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Physiological importance of dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Plasma dehydroepiandrosterone sulfate in nursing home men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and glucose metabolism in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Neuroendocrine correlates of the type A behavior pattern: a review and new hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

The questionable physiologic and epidemiologic basis for a male climacteric syndrome: preliminary results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Androgens, estrogens, and sex hormone-binding globulin in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Nutrient intakes and blood pressure in normotensive males

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

The relation between dominance, anger, and hormones in normally aging men: results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Measuring the experience, expression, and control of anger

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Steroid and gonadotropin levels in women during the peri-menopausal years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Sex-hormone-binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

24-Hour Secretory Pattern of Dehydroisoandrosterone and Dehydroisoandrosterone Sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone) and coronary arteriosclerosis in men: The lower the androgens, the higher the coronary score of arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2F153.1.79

21 January 2018

Identifiers

DOI

10.1093/AJE/153.1.79

1 reference

4 July 2017

1 reference